EquityIndex FundsVery High Risk
Direct
NAV (16-Oct-25)
Returns (Since Inception)
Fund Size
₹201 Cr
Expense Ratio
0.49%
ISIN
INF277KA1CI7
Minimum SIP
₹1,000
Exit Load
No Charges
Inception Date
05 Sep 2024
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
-11.19%
— (Cat Avg.)
Since Inception
-11.39%
— (Cat Avg.)
Equity | ₹201.61 Cr | 100.06% |
Others | ₹-0.11 Cr | -0.06% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Fortis Healthcare Ltd | Equity | ₹10.49 Cr | 5.21% |
Coforge Ltd | Equity | ₹10.21 Cr | 5.06% |
BSE Ltd | Equity | ₹10.2 Cr | 5.06% |
Max Financial Services Ltd | Equity | ₹9.73 Cr | 4.83% |
One97 Communications Ltd | Equity | ₹9.67 Cr | 4.80% |
Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹9.31 Cr | 4.62% |
Dixon Technologies (India) Ltd | Equity | ₹7.94 Cr | 3.94% |
Eternal Ltd | Equity | ₹7.92 Cr | 3.93% |
Muthoot Finance Ltd | Equity | ₹7.73 Cr | 3.84% |
HDFC Asset Management Co Ltd | Equity | ₹7.52 Cr | 3.73% |
Solar Industries India Ltd | Equity | ₹7.49 Cr | 3.72% |
Bharat Electronics Ltd | Equity | ₹7.42 Cr | 3.68% |
Eicher Motors Ltd | Equity | ₹7.1 Cr | 3.52% |
Bosch Ltd | Equity | ₹6.68 Cr | 3.32% |
Bajaj Finance Ltd | Equity | ₹6.62 Cr | 3.28% |
Indian Hotels Co Ltd | Equity | ₹6.04 Cr | 3.00% |
TVS Motor Co Ltd | Equity | ₹5.85 Cr | 2.90% |
UPL Ltd | Equity | ₹5.6 Cr | 2.78% |
Bharti Airtel Ltd | Equity | ₹5.47 Cr | 2.72% |
Maruti Suzuki India Ltd | Equity | ₹5.42 Cr | 2.69% |
Aditya Birla Capital Ltd | Equity | ₹5.24 Cr | 2.60% |
Mahindra & Mahindra Ltd | Equity | ₹5.22 Cr | 2.59% |
Divi's Laboratories Ltd | Equity | ₹5.19 Cr | 2.57% |
Indian Bank | Equity | ₹5.12 Cr | 2.54% |
InterGlobe Aviation Ltd | Equity | ₹5.07 Cr | 2.52% |
Mazagon Dock Shipbuilders Ltd | Equity | ₹4.92 Cr | 2.44% |
HDFC Bank Ltd | Equity | ₹4.83 Cr | 2.40% |
L&T Finance Ltd | Equity | ₹4.76 Cr | 2.36% |
Net Current Liabilities | Cash | ₹-4.05 Cr | 2.01% |
A) Repo | Cash - Repurchase Agreement | ₹3.94 Cr | 1.95% |
SBI Cards and Payment Services Ltd Ordinary Shares | Equity | ₹3.59 Cr | 1.78% |
Glenmark Pharmaceuticals Ltd | Equity | ₹3.25 Cr | 1.61% |
Large Cap Stocks
46.58%
Mid Cap Stocks
53.47%
Small Cap Stocks
--
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Financial Services | ₹65.34 Cr | 32.43% |
Consumer Cyclical | ₹44.23 Cr | 21.95% |
Healthcare | ₹28.24 Cr | 14.01% |
Technology | ₹27.82 Cr | 13.81% |
Industrials | ₹17.41 Cr | 8.64% |
Basic Materials | ₹13.09 Cr | 6.50% |
Communication Services | ₹5.47 Cr | 2.72% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since December 2024
Since July 2025
ISIN INF277KA1CI7 | Expense Ratio 0.49% | Exit Load No Charges | Fund Size ₹201 Cr | Age 1 year 1 month | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty200 Alpha 30 Index |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Total AUM
₹2,14,638 Cr
Address
Mafatlal Centre, 9th Floor, Mumbai, 400 021
Your principal amount will be at Very High Risk
EquityIndex FundsVery High Risk
Direct
NAV (16-Oct-25)
Returns (Since Inception)
Fund Size
₹201 Cr
Expense Ratio
0.49%
ISIN
INF277KA1CI7
Minimum SIP
₹1,000
Exit Load
No Charges
Inception Date
05 Sep 2024
Your principal amount will be at Very High Risk
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
-11.19%
— (Cat Avg.)
Since Inception
-11.39%
— (Cat Avg.)
Equity | ₹201.61 Cr | 100.06% |
Others | ₹-0.11 Cr | -0.06% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Fortis Healthcare Ltd | Equity | ₹10.49 Cr | 5.21% |
Coforge Ltd | Equity | ₹10.21 Cr | 5.06% |
BSE Ltd | Equity | ₹10.2 Cr | 5.06% |
Max Financial Services Ltd | Equity | ₹9.73 Cr | 4.83% |
One97 Communications Ltd | Equity | ₹9.67 Cr | 4.80% |
Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹9.31 Cr | 4.62% |
Dixon Technologies (India) Ltd | Equity | ₹7.94 Cr | 3.94% |
Eternal Ltd | Equity | ₹7.92 Cr | 3.93% |
Muthoot Finance Ltd | Equity | ₹7.73 Cr | 3.84% |
HDFC Asset Management Co Ltd | Equity | ₹7.52 Cr | 3.73% |
Solar Industries India Ltd | Equity | ₹7.49 Cr | 3.72% |
Bharat Electronics Ltd | Equity | ₹7.42 Cr | 3.68% |
Eicher Motors Ltd | Equity | ₹7.1 Cr | 3.52% |
Bosch Ltd | Equity | ₹6.68 Cr | 3.32% |
Bajaj Finance Ltd | Equity | ₹6.62 Cr | 3.28% |
Indian Hotels Co Ltd | Equity | ₹6.04 Cr | 3.00% |
TVS Motor Co Ltd | Equity | ₹5.85 Cr | 2.90% |
UPL Ltd | Equity | ₹5.6 Cr | 2.78% |
Bharti Airtel Ltd | Equity | ₹5.47 Cr | 2.72% |
Maruti Suzuki India Ltd | Equity | ₹5.42 Cr | 2.69% |
Aditya Birla Capital Ltd | Equity | ₹5.24 Cr | 2.60% |
Mahindra & Mahindra Ltd | Equity | ₹5.22 Cr | 2.59% |
Divi's Laboratories Ltd | Equity | ₹5.19 Cr | 2.57% |
Indian Bank | Equity | ₹5.12 Cr | 2.54% |
InterGlobe Aviation Ltd | Equity | ₹5.07 Cr | 2.52% |
Mazagon Dock Shipbuilders Ltd | Equity | ₹4.92 Cr | 2.44% |
HDFC Bank Ltd | Equity | ₹4.83 Cr | 2.40% |
L&T Finance Ltd | Equity | ₹4.76 Cr | 2.36% |
Net Current Liabilities | Cash | ₹-4.05 Cr | 2.01% |
A) Repo | Cash - Repurchase Agreement | ₹3.94 Cr | 1.95% |
SBI Cards and Payment Services Ltd Ordinary Shares | Equity | ₹3.59 Cr | 1.78% |
Glenmark Pharmaceuticals Ltd | Equity | ₹3.25 Cr | 1.61% |
Large Cap Stocks
46.58%
Mid Cap Stocks
53.47%
Small Cap Stocks
--
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Financial Services | ₹65.34 Cr | 32.43% |
Consumer Cyclical | ₹44.23 Cr | 21.95% |
Healthcare | ₹28.24 Cr | 14.01% |
Technology | ₹27.82 Cr | 13.81% |
Industrials | ₹17.41 Cr | 8.64% |
Basic Materials | ₹13.09 Cr | 6.50% |
Communication Services | ₹5.47 Cr | 2.72% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since December 2024
Since July 2025
ISIN INF277KA1CI7 | Expense Ratio 0.49% | Exit Load No Charges | Fund Size ₹201 Cr | Age 1 year 1 month | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty200 Alpha 30 Index |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Total AUM
₹2,14,638 Cr
Address
Mafatlal Centre, 9th Floor, Mumbai, 400 021
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments